Back

PROTECT Peanut Allergy Study

Official Title

VLP-101

Study Details

The purpose of the study is to test the safety and efficacy of a study drug meant to prevent allergic reactions to peanuts.

Principal Investigator

Dr. H. James Wedner

IRB Number

202207164

Eligibility

1. Participants must be 18 to 50 years old
2. Participants must have physician diagnosed peanut allergy

Compensation is provided for time and effort (contact the study team for compensation amount).

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back